Position in MRK
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,530,692
+$102,369 QoQ
Shares Held
11,912
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,782
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $28,490,833 across 13 Drug Manufacturers - General names. MRK ranks #4 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,081 | $14,490,315 | |
| 2 | ABBV |
AbbVie Inc.
|
13,295 | $3,345,553 | |
| 3 | JNJ |
Johnson & Johnson
|
12,384 | $3,145,164 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
11,912 | $1,530,692 | |
| 5 | AMGN |
Amgen Inc
|
3,413 | $1,235,915 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,694 | $972,059 | |
| 7 | NVS |
Novartis AG
|
5,748 | $900,826 | |
| 8 | PFE |
Pfizer Inc
|
36,772 | $885,469 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,530,692 | 11,912 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,428,323 | 11,874 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $3,336,636 | 31,699 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,094,724 | 24,958 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $1,867,146 | 23,587 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $2,127,850 | 23,706 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,084,928 | 10,906 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $1,436,420 | 12,649 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,594,296 | 12,878 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $1,675,765 | 12,700 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,409,737 | 12,931 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $1,374,176 | 13,348 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,673,616 | 14,504 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,129,289 | 20,014 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $1,988,445 | 17,922 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,552,571 | 18,028 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $1,616,626 | 17,732 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,272,021 | 15,503 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,136,034 | 14,823 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,061,679 | 14,135 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,004,244 | 12,913 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $912,360 | 11,835 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,004,421 | 12,279 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,097,760 | 13,234 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $916,979 | 11,858 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $918,894 | 11,943 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||